Ivermectin has shown promise as a potential treatment. It needs to be urgently evaluated under the guidance of the FDA

U.S. adults reporting symptoms of anxiety disorder and/or depressive disorder rose from 11% in the first half of 2019 to more than 40% in January 2021.

Thalidomide’s history is a grim reminder of what can go wrong when a drug comes to market without proper clinical trials and oversight.

Our survival as a species could be placed in jeopardy if we don't begin to police treatments that place our DNA in harms way. Oversight is needed.